Nahad Sedaghat

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Respiratory Syndrome Coronavirus

Candida Albicans

Diffuse Large B Cell Lymphoma

Top Venues

Scientific reports

Clinical case reports

Human vaccines & immunotherapeutics

Journal of neurology, neurosurgery, and psychiatry

This page only lists publications with an associated author ORCID identifier.

Publications

Masoud Etemadifar, Seyyed-Ali Alaei, Mehri Salari, Nahad Sedaghat
Span of spleen is associated with disability status in multiple sclerosis: a cross-sectional abdominopelvic ultrasonography study. Scientific reports 14 (1) (2024)
Masoud Etemadifar, Seyyed-Ali Alaei, Mehri Salari, Nahad Sedaghat
Span of spleen is associated with disability status in multiple sclerosis: a cross-sectional abdominopelvic ultrasonography study. Scientific reports 14 (1) (2024)
Masoud Etemadifar, Seyyed-Ali Alaei, Mehri Salari, Nahad Sedaghat
Span of spleen is associated with disability status in multiple sclerosis: a cross-sectional abdominopelvic ultrasonography study. Scientific reports 14 (1) (2024)
Mohammad Minakari, Nahad Sedaghat
Endoscopic clipping of a complicated esophageal perforation following pneumatic dilation for achalasia: A case study and literature review. Clinical case reports 10 (11) (2022)
Masoud Etemadifar, Hosein Nouri, Maristella Pitzalis, Maria Laura Idda, Mehri Salari, Mahshid Baratian, Sepide Mahdavi, Amir Parsa Abhari, Nahad Sedaghat
Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis. Journal of neurology, neurosurgery, and psychiatry 93 (9) (2022)
Masoud Etemadifar, Hosein Nouri, Mehri Salari, Nahad Sedaghat
Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse. Human vaccines & immunotherapeutics 18 (1) (2022)
Masoud Etemadifar, Amir Parsa Abhari, Hosein Nouri, Amirhossein Akhavan Sigari, Seyed Mohammad Piran Daliyeh, Mohammad Reza Maracy, Mehri Salari, Shiva Maleki, Nahad Sedaghat
Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis. Human vaccines & immunotherapeutics 18 (1) (2022)
Niloofar Najarzadegan, Mahboobeh Madani, Masoud Etemadifar, Nahad Sedaghat
Immunomodulatory drug fingolimod (FTY720) restricts the growth of opportunistic yeast Candida albicans in vitro and in a mouse candidiasis model. PloS one 17 (12) (2022)
Masoud Etemadifar, Amir Parsa Abhari, Hosein Nouri, Mehri Salari, Shiva Maleki, Alireza Amin, Nahad Sedaghat
Does COVID-19 increase the long-term relapsing-remitting multiple sclerosis clinical activity? A cohort study. BMC neurology 22 (1) (2022)
Masoud Etemadifar, Armin Mehri, Nahad Sedaghat, Mehri Salari, Parsa Tavassoli Naini
Multiple sclerosis in sarcoidosis patients: Two case reports. Clinical case reports 10 (9) (2022)
Sayed Lotfollah Afzali, Hesam Panahi, Forouzan Ganji, Sanaz Ziaei, Nahad Sedaghat
Re-Evaluating the Effect of Preoperative Tranexamic Acid on Blood Loss and Field Quality During Rhinoplasty: A Randomized Double-Blinded Controlled Trial. Aesthetic plastic surgery (2021)